Aurobindo Pharma Limited
AUROPHARMA
Rankning i aktier
#2066
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aktiekurs
$16.49
Marknadsvärde
$9.49B
Förändring (1 dag)
-4.89%
Förändring (1 år)
31.92%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)
Kategori
Healthcare
Historik för aktiesplit för Aurobindo Pharma Limited (AUROPHARMA)
Aktien Aurobindo Pharma Limited (symbol: AUROPHARMA) har genomgått totalt 5 aktiesplitar.
Den senaste spliten skedde den Jul 20, 2015.
En AUROPHARMA-aktie köpt före Oct 26, 1998 motsvarar nu 80 AUROPHARMA-aktier.
Den senaste spliten skedde den Jul 20, 2015.
En AUROPHARMA-aktie köpt före Oct 26, 1998 motsvarar nu 80 AUROPHARMA-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2015-07-20 | 2:1 | x2 | x80 |
| 2011-02-10 | 5:1 | x5 | x40 |
| 2003-10-23 | 2:1 | x2 | x8 |
| 2000-03-20 | 2:1 | x2 | x4 |
| 1998-10-26 | 2:1 | x2 | x2 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 0 | - |
CN
|
